HIVE Digital Technologies Welcomes Lieutenant General (Ret.) John R. Evans Jr. to Global Strategy Advisory Committee

Breaking News: HIVE Digital Technologies Ltd. Makes Designated News Release Introduction In a recent announcement, HIVE Digital Technologies Ltd. has issued a designated news release in accordance with their prospectus supplement dated October 3, 2024. This news has created waves in the industry and has sparked interest and speculation among investors and industry experts. Details…

Read More

“Revolutionizing STI Diagnosis: Roche’s cobas® Liat Molecular Tests Receive FDA Clearance with CLIA Waiver for Point-of-Care Testing”

Basel, 22 January 2025 – Roche Receives FDA Clearance for cobas® liat STI Multiplex Assay Panels Revolutionizing STI Diagnosis Roche, a global leader in healthcare, has made a significant breakthrough in the field of sexually transmitted infection (STI) diagnosis. The company announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance…

Read More

Sarclisa Approved in the EU as First Anti-CD38 Therapy in Combination with Standard of Care VRd to Treat Transplant-Ineligible Newly Diagnosed Multiple Myeloma

Sarclisa Approved in the EU: A Milestone in Multiple Myeloma Treatment Introduction Recently, Sarclisa received approval in the European Union as the first anti-CD38 therapy to be used in combination with standard-of-care VRd for the treatment of transplant-ineligible newly diagnosed multiple myeloma patients. This marks a significant milestone in the field of oncology and provides…

Read More

“Vitalik’s Wartime Adventures: How Defi Became the Milady of the Ethereum Foundation”

Vitalik Buterin: Embracing Change in the Ethereum Community A New Direction for Ethereum As Vitalik Buterin takes on a more prominent role in revamping the Ethereum Foundation, he is also taking a stand against the aggressive online culture that has permeated the crypto community. Known for his innovative ideas and forward-thinking approach, Buterin is not…

Read More